NYSEMKT: OGENOragenics Inc Stock Ownership - Who owns Oragenics?
Insider buying vs selling
Have Oragenics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Odyssey Health Inc | 10% Owner | 2025-06-18 | 5,044 | $4.26 | $21.49kSell |
| Odyssey Health Inc | 10% Owner | 2025-06-17 | 2,000 | $4.46 | $8.92kSell |
| Odyssey Health Inc | 10% Owner | 2025-06-16 | 5,000 | $4.45 | $22.25kSell |
| Odyssey Health Inc | 10% Owner | 2025-06-13 | 5,000 | $4.27 | $21.35kSell |
OGEN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when OGEN insiders and whales buy or sell their stock.
OGEN Shareholders
What type of owners hold Oragenics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Randal J. Kirk | 476.80% | 19,874,069 | $18.66M | Insider |
| Koski Family LP | 235.92% | 9,833,595 | $9.23M | Insider |
| Jeffrey D. Hillman | 78.70% | 3,280,434 | $3.08M | Insider |
| Christine L. Koski | 50.38% | 2,100,000 | $1.97M | Insider |
| David Brian Hirsch | 23.99% | 1,000,000 | $939.00k | Insider |
| Robert T. Zahradnik | 21.14% | 881,000 | $827.26k | Insider |
| George T. Hawes | 17.88% | 745,397 | $699.93k | Insider |
| Mento Soponis | 12.48% | 520,133 | $488.40k | Insider |
| John N. Bonfiglio | 9.24% | 385,255 | $361.75k | Insider |
| Bruce A. Cassidy Sr. | 8.51% | 354,728 | $333.09k | Insider |
OGEN vs Biotech Stocks
Oragenics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.